Business Technology

Diabetes management trends

Last updated: May 26, 2011 4:17 pm

PatrickDriscoll

2 Min Read

As a chronic disease that is strongly tied to trends in demographics, incidence/prevalence and other forces, diabetes is inexorably growing in its impact on healthcare and, therefore, the need for effective products in its management.

There is growth across the board for all product types, including glucose meters, lancets, test strips, continuous blood glucose meters, insulin, insulin pumps, syringes and other insulin delivery devices, and anti-diabetic drugs.

As a chronic disease that is strongly tied to trends in demographics, incidence/prevalence and other forces, diabetes is inexorably growing in its impact on healthcare and, therefore, the need for effective products in its management.

There is growth across the board for all product types, including glucose meters, lancets, test strips, continuous blood glucose meters, insulin, insulin pumps, syringes and other insulin delivery devices, and anti-diabetic drugs.

Source: MedMarket Diligence, LLC; Report #D510, “Diabetes Management: Products, Technologies, Markets and Opportunities Worldwide 2009-2018.”

While all segments are growing, the opportunity to innovate is resulting in the sales of products in diabetes management trending at different rates, from a low of 8% annually to a high of almost 20% annually. Consequently, the makeup of this market is steadily changing over time.

Source: MedMarket Diligence, LLC; Report #D510, “Diabetes Management: Products, Technologies, Markets and Opportunities Worldwide 2009-2018.”

TAGGED:diabetes health care business medical technology

Share This Article

By PatrickDriscoll

Follow:

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.